Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer

Journal of Magnetic Resonance Imaging

Volumn 39, Issue 1, 2014, Pages 172-178

  Kobayashi, Shuichiro ^a   Koga, Fumitaka ^a   Kajino, Kohei ^a   Yoshita, Soichiro ^a   Ishii, Chikako ^a   Tanaka, Hiroshi ^b   Saito, Kazutaka ^a   Masuda, Hitoshi ^a   Fujii, Yasuhisa ^a   Yamada, Tetsuo ^a   Kihara, Kazunori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Ochanomizu Surugadai Clinic   (Japan)

Author keywords

apparent diffusion coefficient; bladder cancer; diffusion weighted magnetic resonance imaging; Ki 67 antigen

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BLADDER CANCER; CANCER PROGNOSIS; CANCER STAGING; CELL PROLIFERATION; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE BLADDER CANCER; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR INVASION; TUMOR VOLUME;

APPARENT DIFFUSION COEFFICIENT; BLADDER CANCER; DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING; KI-67 ANTIGEN;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CELL PROLIFERATION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROGNOSIS; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84890472348     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24148     Document Type: Article

References (35)

1. Jacobs BL, Lee CT, Montie JE,. Bladder cancer in 2010: how far have we come? CA Cancer J Clin 2010; 60: 244-272.
2. Shariat SF, Tokunaga H, Zhou J, et al. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J Clin Oncol 2004; 22: 1014-1024.
3. Stein JP, Ginsberg DA, Grossfeld GD, et al. Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J Natl Cancer Inst 1998; 90: 1072-1079.
4. Krüger S, Weitsch G, Buttner H, et al. HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications. Int J Cancer 2002; 102: 514-518.
5. Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20.
6. Margulis V, Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y,. Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease. Clin Cancer Res 2006; 12: 7369-7373.
7. Quintero A, Alvarez-Kindelan J, Luque RJ, et al. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder. J Clin Pathol 2006; 59: 83-88.
8. Margulis V, Lotan Y, Karakiewicz PI, et al. Multi-institutional validation of the predictive value of Ki-67 Labeling Index in patients with urinary bladder cancer. J Natl Cancer Inst 2009; 101: 114-119.
9. Woodhams R, Matsunaga K, Iwabuchi K, et al. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005; 29: 644-649.
10. Yoshida S, Masuda H, Ishii C, Saito K, Kawakami S, Kihara K,. Initial experience of functional imaging of upper urinary tract neoplasm by diffusion-weighted magnetic resonance imaging. Int J Urol 2008; 15: 140-143.
11. Zhang J, Tehrani YM, Wang L, Ishill NM, Schwartz LH, Hricak H,. Renal masses: characterization with diffusion-weighted MR imaging-a preliminary experience. Radiology 2008; 247: 458-464.
12. Shinya S, Sasaki T, Nakagawa Y, Guiquing Z, Yamamoto F, Yamashita Y,. The usefulness of diffusion-weighted imaging (DWI) for the detection of gastric cancer. Hepatogastroenterology 2007; 54: 1378-1381.
13. Tamada T, Sone T, Jo Y, et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 2008; 28: 720-726.
14. Yoshida S, Masuda H, Ishii C, et al. Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer. AJR Am J Roentgenol 2011; 196: 110-116.
15. Takeuchi M, Sasaki S, Ito M, et al. Urinary bladder cancer: diffusion-weighted MR imaging - accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009; 251: 112-121.
16. Kobayashi S, Koga F, Yoshida S, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol 2011; 21: 2178-2186.
17. Yoshida S, Koga F, Kawakami S, et al. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology 2010; 75: 387-391.
18. Yoshida S, Koga F, Kobayashi S, et al. Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 2012; 83: 21-27.
19. Mostofi FK, Sobin LH, Torloni H,. Histological typing of urinary bladder tumours. Geneva: World Health Organization; 1973.
20. Sobin LH, Gospodariwicz M, Wittekind C,. TNM classification of malignant tumors. UICC International Union Against Cancer, 7th edition. New York: Wiley-Blackwell; 2011. p 262-265.
21. Babjuk M, Oosterlinck W, Sylvester R, et al. European Association of Urology (EAU). EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 2011; 59: 997-1008.
22. Akaike H,. A new look at the statistical model identification. IEEE Trans Automat Contr 1974; 19: 716-723.
23. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11: 102-125.
24. Yoshikawa MI, Ohsumi S, Sugata S, et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med 2008; 26: 222-226.
25. Guo AC, Cummings TJ, Dash RC, Provenzale JM,. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002; 224: 177-183.
26. Xu J, Does MD, Gore JC,. Sensitivity of MR diffusion measurements to variations in intracellular structure: effects of nuclear size. Magn Reson Med 2009; 61: 828-833.
27. Chen Z, Ma L, Lou X, Zhou Z,. Diagnostic value of minimum apparent diffusion coefficient values in prediction of neuroepithelial tumor grading. J Magn Reson Imaging 2010; 31: 1331-1338.
28. Choi SY, Chang YW, Park HJ, Kim HJ, Hong SS, Seo DY,. Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer. Br J Radiol 2012; 85: e474-e479.
29. Koga F, Yoshida S, Tatokoro M, et al. ErbB2 and NFκB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancer. PLoS One 2011; 6: e27616.
30. Rosenkrantz AB, Mussi TC, Spieler B, Melamed J, Taneja SS, Huang WC,. High-grade bladder cancer: association of the apparent diffusion coefficient with metastatic disease: preliminary results. J Magn Reson Imaging 2012; 35: 1478-1483.
31. Funatsu H, Imamura A, Takano H, Ueda T, Uno T,. Can pretreatment ADC values predict recurrence of bladder cancer after transurethral resection? Eur J Radiol 2012; 81: 3115-3119.
32. Higano S, Yun X, Kumabe T, et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 2006; 241: 839-846.
33. Murakami R, Sugahara T, Nakamura H, et al. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 2007; 243: 493-499.
34. Koga F, Yoshida S, Kawakami S, et al. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology 2008; 72: 384-388.
35. Sasaki M, Yamada K, Watanabe Y, et al. Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology 2008; 249: 624-630.